Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma

Journal of Nuclear Medicine

Volumn 39, Issue 7, 1998, Pages 1197-1202

  Dimitrakopoulou Strauss, Antonia ^a   Strauss, Ludwig G ^b   Schlag, Peter ^b   Hohenberger, Peter ^b   Möhler, Markus ^b   Oberdorfer, Franz ^b   Van Kaick, Gerhard ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

Fluorine 18 flourouracil; Liver metastases; Liver treatment; PET

Indexed keywords

BETA ALANINE; CYTOSTATIC AGENT; FLUORINE 18; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL PROTOCOL; COLORECTAL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; HUMAN; HUMAN TISSUE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FLUORINE RADIOISOTOPES; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031815958     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kemeny N. The systemic chemotherapy of hepatic metastases. Semin Oncol 1983;10: 148-158.
2. Niederhuber JE, Ensminger WD. Surgical consideration in the management of hepatic neoplasia. Semin Oncol 1983;10:135-147.
3. Huberman MS. Comparison of systemic chemotherapy with hepatic arterial infusion in metastatic colorectal carcinoma. Semin Oncol 1983;10:238-248.
4. Vaughn DJ, Haller DG. Nonsurgical management of reccurent colorectal cancer. Cancer 1993;71:4278-4292.
5. Lokich JL. Determination of response in treatment of hepatic neoplasia. Semin Oncol 1983;10:228-237.
6. Findlay M, Young H, Cunningham D, et al. Noninvasive monitoring of tumor metabolism using fluordeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol 1996;14:700-708.
7. Dimitrakopoulou A, Strauss LG, Clorius JH, et al. Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. J Nucl Med 1993;34:1075-1081.
8. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
9. 18F-fluorouracil in patients with metastatic colorectal cancer. J Nucl Med 1998;39:465-473.
10. 18F-labeled 5-flourouracil of very high purity. J Lab Compds Radiopharm 1989;27:137-145.
11. Doll J, Ostertag HJ, Bellemann ME, et al. Effects of distorted PET projection data on the reconstructed image using different reconstruction algorithms. In: Bergmann H, Sinzinger H eds. Radioactive isotopes in clinical medicine and research advances in pharmacological sciences. Basel: Birkhäuser Verlag; 1995:85-90.
12. Ostertag H, Kübler WK, Doll J, Lorenz WJ. Measured attenuation correction methods. Eur J Nucl Med 1989;15:722-726.
13. Hoverath H, Kübler WK, Ostertag H, et al. Scatter correction in the transaxial slices of a whole-body position emission tomograph. Phys Med Biol 1993:717-728.
14. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329-332.
15. Semmler W, Bachert-Baumann P, Gückel F, et al. Real-time follow-up of 5-flourouracil metabolism in the liver of tumor patients by means of F-19 MR spectroscopy. Radiology 1990;174:141-145.
16. Strauss LG. Application of positron emission tomography in colorectal carcinoma. Onkologie 1993;16:232-244.
17. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, van Kaick G. Evaluation of tumour metablosim and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 1995;22:434-442.
18. Boyle FM, Smith RC, Levi JA. Continuous hepatic artery infusion of 5-flourouracil for metastatic clorectal cancer localised to the liver. Aust N Z J Med 1993;23:32-34.
19. De Takats PG, Kerr DJ, Poole CJ, et al. Hepatic arterial chemotherapy for metastatic colorectal carcinoma. Br J Cancer 1994;69:372-378.
20. Chaudhuri NK, Murkherjee KL, Heidelberger C. Studies of flourinated pyrimidines-VII-the degradative pathway. Biochem Pharmacol 1959;1:328-341.
21. 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci USA 1990;87:492-496.
22. 18F-flourouracil in sensitive versus resistant lymphocytic leukemia in mice. Cancer Res 1977;37:2306-2308.